Singular Genomics Appoints John Stark as CEO
Singular Genomics has appointed John Stark as Chief Executive Officer, announced in a press release. The leadership change comes as the company advances its spatial genomics platform and seeks to expand adoption across research and clinical markets.
Stark succeeds Josh Stahl, who will transition to the role of Independent Director on the Board. The company stated that with its G4X Spatial Sequencer now commercially available, the focus will shift to scaling operations and strengthening strategic partnerships.
John Stark brings more than 25 years of experience in commercializing life science technologies. He previously served as CEO of Resolve Biosciences, Quantum-Si, and Celsee, and held senior roles at Life Technologies, Pacific Biosciences, and Affymetrix.
Based in San Diego, Singular Genomics develops high throughput spatial pathology solutions for translational research, drug development, and precision medicine.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 McGraw Hill Adds AI Study Tools to Connect Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Prologue Medicines names Stephen Harrison chief scientific officer
DeepSight Technology Adds Scott Huennekens to Board
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
NuSummit Appoints Kunal Purohit as CEO
INmune Bio and QCi Apply Quantum Computing to XPro Research
Daily AI Brief: the AI news that matters, in your inbox.